Edwards Lifesciences (EW): Analysts Lower PT After 3Q Preliminary Sales
Posted on October 09, 2012 at 12:15 PM EDT
Atleast two brokerages have lowered their price targets on Edwards Lifesciences Corp. (NYSE:EW) after the company slashed its third-quarter sales outlook, citing lower-than-expected transcatheter heart valve sales. On Tuesday, shares plunged nearly 20 percent in early trade following the preannouncement. [More...]